Cynthia Jurado Marquez
Family · Sioux City, IANPI 1972337608
Payments from drug & device makers
Across 143 payments — averaging $21.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$426
- Incyte Corporation$294
- Ipsen Biopharmaceuticals, Inc$252
- AbbVie$223
- Daiichi Sankyo Inc.$189
- Merck$183
- plus $1K from 34 others
What the payments were for
- Food & beverage$2,28376%
- Education$72824%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 21 | $426 |
| Incyte Corporation | 10 | $294 |
| Ipsen Biopharmaceuticals, Inc | 5 | $252 |
| AbbVie | 7 | $223 |
| Daiichi Sankyo Inc. | 9 | $189 |
| Merck | 12 | $183 |
| Novartis | 8 | $150 |
| E.r. Squibb & Sons, L.L.C. | 7 | $136 |
| Servier Pharmaceuticals LLC | 6 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $87 |
| Exelixis Inc. | 1 | $75 |
| Pharmaessentia USA Corporation | 3 | $67 |
| Pfizer | 3 | $64 |
| Bayer | 3 | $52 |
| Eisai Inc. | 3 | $52 |
| Stemline Therapeutics Inc. | 3 | $48 |
| Lilly USA, LLC | 3 | $45 |
| Gilead(2 entities) | 3 | $43 |
| Iovance Biotherapeutics, Inc. | 2 | $41 |
| Boston Scientific | 2 | $37 |
| Caris MPI, Inc. | 2 | $37 |
| AVEO Pharmaceuticals, Inc. | 2 | $34 |
| Adaptive Biotechnologies Corporation | 2 | $31 |
| Progenics Pharmaceuticals, Inc. | 2 | $30 |
| AstraZeneca(2 entities) | 2 | $28 |
| GSK | 2 | $27 |
| Puma Biotechnology, Inc. | 2 | $27 |
| Taiho Oncology, Inc. | 1 | $25 |
| Sun Pharmaceutical Industries Inc. | 1 | $23 |
| Accord Healthcare, Inc. | 1 | $19 |
| Genmab U.S., Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Pharmacosmos Therapeutics Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $15 |
| Sobi, Inc | 1 | $15 |
| Beone Medicines USA, Inc. | 1 | $14 |
| Blue Earth Diagnostics | 1 | $14 |
| EMD Serono, Inc. | 1 | $13 |
| Organon | 1 | $7 |
How this compares
$3,011 in reported general payments places this provider in the 90th percentile of 1,268 family providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prochlorperazine Maleate | 14 | $120 |
| Ondansetron Hcl | 17 | $112 |
| Anastrozole | 16 | $73 |
| Levofloxacin | 14 | $67 |
Paid to pharmacies, not to this prescriber.
Other family in Sioux City
- Jaclyn MeisSioux City$14K
- Katherine WanderscheidSioux City$4K
- Courtney MayoSioux City$3K
- Stefanie GaticaAnkeny$354K
- Aubrey MolgaardAmes$238K
- Joan KittenFort Dodge$85K
- Megan FergusonPella$82K
- Rodney ClarkDes Moines$63K
- Jennifer CondonFort Dodge$31K
- Karen HunkeAmes$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.